Senator Grisanti Tours RPCI Facility

Thursday, July 14, 2011

New York State Senator Mark Grisanti made his first official visit to Roswell Park Cancer Institute on Wed., July 13, meeting with President and CEO Donald L. Trump, MD, and getting a behind-the-scenes tour of the Therapeutic Cell Production Facility, the only laboratory of its kind in the world.

During his visit to the Facility, which is a critical component of RPCI’s Center for Immunotherapy, Senator Grisanti learned about how its Director, Christopher Choi, PhD, and his team are working to bring personalized treatments to cancer patients. The Facility is a Clinical Good Manufacturing Practices (cGMP) laboratory created to manufacture compounds that use our bodies’ own immune systems to treat infection and disease. 

Media Contact: 

Annie Deck-Miller, Senior Media Relations Manager
716-845-8593; annie.deck-miller@roswellpark.org